[New fields of cyclosporin A (sandimmun) application in rheumatology: treatment of systemic lupus erythematosus].
Nasonov
E L
EL
Kliukvina
N G
NG
Shekshina
S V
SV
Nasonova
V A
VA
D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D018664:Interleukin-12 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000276:immunology; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D012219:Rheumatology / Q000379:methods*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D015850:Interleukin-6; D018664:Interleukin-12; D016572:Cyclosporine